We found that C3G was a much more economical, safe and stable agent that could inhibit ferroptosis by regulating the system Xc ̄-GSH-GPX4 axis, activating the AMPK pathway and reducing ACSL4-dependent lipid biosynthesis, providing novel insight and a potential strategy for the treatment of AKI. The gene discussed is ACSL4; the disease is acute kidney injury.